
1. vaccine. 2008 may 23;26(22):2738-45. doi: 10.1016/j.vaccine.2008.03.019. epub
2008 apr 1.

immunization hiv-1 immunogen induces cd4+ cd8+ hiv-1-specific
polyfunctional responses patients chronic hiv-1 infection receiving
antiretroviral therapy.

valor l(1), navarro j, carbone j, rodríguez-sáinz c, gil j, lópez f,
fernández-cruz e; stir-2102 team.

collaborators: desco m, rodríguez-molina j, bouza e, pérez molina j, peña jm,
podzamczer d, ferrer e, ocaña i, díaz m, clotet b, jou a, sirera g, rubio r,
pulido f, viciana p, maradona ja, blazquez r, barros c, moreno s, quereda c,
gatell jm, gonzález-lahoz j.

author information: 
(1)division immunology, university general hospital gregorio marañón, madrid, 
spain.

development polyfunctional lymphocyte responses critical the
immunological response hiv-1. fifty-four hiv-1 infected patients
receiving antiretroviral treatment (art) immunization hiv-1 immunogen
or placebo, periodically every 3 months throughout period 36 months, were
evaluated purposes analysing development hiv-1-specific cd4+
and cd8+ responses. significant increase proliferating ifn-gamma
producing cd8+ hiv-1-specific cells, hiv-1-specific precursor frequencies
for cd8+ cd4+ cells gag/pol-specific memory ctl precursors
(ctlp) observed immunogen group comparison placebo. il-2
intracellular expression ifn-gamma tnf-alpha co-expression in
hiv-1-specific cd8+ cells also substantially increased immunized
group. negative correlation viral load cd3+cd4+cfselow
hiv-1-specific lymphoproliferative response frequency gag/pol-specific
ctlp solely observed hiv-1 immunogen group. long-term immunization 
patients receiving art helps develop hiv-1-specific polyfunctional cell
responses.

doi: 10.1016/j.vaccine.2008.03.019 
pmid: 18433946  [indexed medline]

